The Primary
Care Companionfor CNS Disorders

Depression (MDD) Electroconvulsive Therapy

Letter to the Editor Difficult to Treat Depression June 4, 2020

Effectiveness and Safety of Intravenous Ketamine for Severely Depressed Patients Unable to Receive Electroconvulsive Therapy Due to Medical Risks

Brett Y. Lu, MD, PhD; James R. Agapoff, IV, MS, MD; Daniel Olson, MD; Wendy Tawata, PharmD; Steven R. Williams, MD; Celia Ona, MD; Barry Carlton, MD

Prim Care Companion CNS Disord 2020;22(3):19l02535

Article Abstract

Free Access: Please Log In

This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.

About the Authors

Buy PDF for $40.00

Please sign in or purchase this PDF for $40.00.

Save

Cite

Read the Current Issue

Original Research

Conflict Mediation by CBT

Systematic Review

Psychiatric Adverse Effects of Hydroxychloroquine

Review Article

Efficacy of GLP-1 Agonists in Mental Disorders

Rounds in the General Hospital

Time-Limited Teaching of Psychiatry to Medical Students

Rounds in the General Hospital

Multimodal Approaches to Pain Management

Rounds in the General Hospital

Sequelae of Adverse Childhood Experiences

View current Issue

Letter to the Editor

Is Bariatric Surgery an Antidepressant?

October 29, 2024

The effect of bariatric surgery on mood disorders is uncertain. Read on to find out more.

Ahmed Naguy

Letter to the Editor

What Clinicians Need to Know About Geriatric Depression

May 16, 2024

The authors discuss what clinicians should be aware of when caring for elderly patients with depression.

Ahmed Naguy, Soliman Al-Khadhari

Letter to the Editor

Intravenous Ketamine vs Intranasal Esketamine for TRD

February 13, 2024

Dr Mansuri and colleagues compare the pros and cons of IV ketamine and intranasal esketamine for treatment-resistant depression.

Hiren Patel, Zeeshan Mansuri, Bhumika Shah, et al

Effectiveness and Safety of Intravenous Ketamine for Severely Depressed Patients Unable to Receive Electroconvulsive Therapy Due to Medical Risks

About the Authors

Read the Current Issue

Conflict Mediation by CBT

Psychiatric Adverse Effects of Hydroxychloroquine

Efficacy of GLP-1 Agonists in Mental Disorders

Time-Limited Teaching of Psychiatry to Medical Students

Multimodal Approaches to Pain Management

Sequelae of Adverse Childhood Experiences

ELSEWHERE:

FOLLOW US:

Effectiveness and Safety of Intravenous Ketamine for Severely Depressed Patients Unable to Receive Electroconvulsive Therapy Due to Medical Risks

Free Access: Please Log In

About the Authors

Read the Current Issue

Conflict Mediation by CBT

Psychiatric Adverse Effects of Hydroxychloroquine

Efficacy of GLP-1 Agonists in Mental Disorders

Time-Limited Teaching of Psychiatry to Medical Students

Multimodal Approaches to Pain Management

Sequelae of Adverse Childhood Experiences

Related Articles

Is Bariatric Surgery an Antidepressant?

What Clinicians Need to Know About Geriatric Depression

Intravenous Ketamine vs Intranasal Esketamine for TRD

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles